戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e scintigraphy with technetium 99m ((99m)Tc) methylene diphosphonate.
2 olyzable GTP analogue guanylyl-(alpha, beta)-methylene-diphosphonate.
3  inhibitor AOPCP [adenosine-5'-O-(alpha,beta-methylene)-diphosphonate] (250 microm).
4 ibitor (TKI)-induced improvements in (99m)Tc-methylene diphosphonate ((99m)Tc-MDP) bone scans.
5   Quantitative studies of bone using (99m)Tc-methylene diphosphonate ((99m)Tc-MDP) have a potentially
6 ntitative studies of the kinetics of (99m)Tc-methylene diphosphonate ((99m)Tc-MDP) in metastatic and
7 rse events in patients who underwent (99m)Tc-methylene diphosphonate ((99m)Tc-MDP) whole-body bone sc
8                                99mTechnetium methylene diphosphonate (99mTc MDP) bone scintigraphy is
9 ith a (99m)Tc-pertechnetate phantom, (99m)Tc-methylene diphosphonate bone imaging, and measurement of
10 nventional imaging (CT or MRI, and a (99m)Tc-methylene diphosphonate bone scan) before enrollment.
11   In an exploratory analysis, paired (99m)Tc-methylene diphosphonate bone scans ((99m)Tc-BS) were ava
12                         Conventional (99m)Tc-methylene diphosphonate bone scans, (201)Tl tumor imagin
13 dine (MIBG), 111In-pentetreotide, and Tc-99m-methylene diphosphonate bone scintigraphy in 30 patients
14 A) and bone scintigraphy with technetium 99m methylene diphosphonate (Fig 1B).
15  bound to the GTP analog guanylyl beta,gamma-methylene-diphosphonate (GMP-PCP) (i.e. the presumed sig
16 drolyzable GTP analog, guanylyl-(alpha,beta)-methylene-diphosphonate (GMPCPP), to examine the structu
17 ling microtubules with guanylyl-(alpha,beta)-methylene-diphosphonate (GMPCPP).
18 wly hydrolyzable GTP analogue guanylyl-(a,b)-methylene-diphosphonate (GMPCPP).
19 imidodiphosphate > MANT-guanylyl-(beta,gamma-methylene)-diphosphonate > MANT-guanosine 5'-O-2-(thio)d
20 ncer patients after a single 600-MBq (99m)Tc-methylene diphosphonate injection.
21 4 mCi 99mTc and 75-125 microCi 111In), 99mTc-methylene diphosphonate (MDP) (3-5 mCi) and 67Ga-citrate
22 ort-lived tracers (18)F-fluoride and (99m)Tc-methylene diphosphonate (MDP) are an alternative method
23                                        99mTc-methylene diphosphonate (MDP) bone scanning was performe
24   Quantitative studies of bone using (99m)Tc-methylene diphosphonate (MDP) reflect bone remodeling.
25        Prominent soft-tissue uptake of 99mTc-methylene diphosphonate (MDP) within the prostate bed wa
26 captoacetyltriglicine chelator (MAG3), 99mTc-methylene diphosphonate (MDP), 99mTc-hexamethylpropylene
27 IM), which included the combination of 99mTc-methylene diphosphonate scintigraphy, CT, or MRI.
28 rotubules capped with guanylyl (alpha, beta)-methylene diphosphonate-tubulin subunits.
29      Bone scintigraphy using (99m)Tc-labeled methylene diphosphonate was performed, and early-phase k
30 n of tetraethyl(2,5-diiodo-1,4-phenylene)bis(methylene)diphosphonate with 10-hexyl-10H-phenothiazine-